TANVI PATEL: Open Payments
NPI 1467039818 · MALVERN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,168 in 96 payments from 17 companies in 2025. Trend: 2023 $1,654 · 2024 $1,645 · 2025 $2,168
Food & beverage: $2,168
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 18 | $454 |
| ABBVIE INC. | 20 | $420 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 10 | $234 |
| Madrigal Pharmaceuticals | 11 | $233 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $209 |
| GENZYME CORPORATION | 5 | $115 |
| Regeneron Healthcare Solutions, Inc. | 5 | $112 |
| Ardelyx, Inc. | 5 | $100 |
| Daiichi Sankyo Inc. | 3 | $73 |
| Aimmune Therapeutics, Inc. | 2 | $58 |
Products named: TREMFYA, RINVOQ, XIFAXAN, REZDIFFRA, DUPIXENT, ENTYVIO, IBSRELA, INJECTAFER.
Industry payments across PA — which companies pay providers there.
